LATOYA DUNCAN: Open Payments
NPI 1760913172 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 38 payments from 11 companies in 2025. Trend: 2023 $142 · 2024 $472 · 2025 $617
Food & beverage: $572Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $175 |
| Lilly USA, LLC | 13 | $141 |
| ABBVIE INC. | 5 | $86 |
| PFIZER INC. | 3 | $71 |
| Ardelyx, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| ViiV Healthcare Company | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: Rybelsus, VRAYLAR, PREVNAR 20, MOUNJARO, Ozempic, ZEPBOUND, IBSRELA, REXULTI.
Industry payments across IL — which companies pay providers there.
